戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sodilating beta-blockers (eg, carvedilol and nebivolol).
2 he beta1-selective affinity of xamoterol and nebivolol.
3 tolic blood pressure from baseline than both nebivolol 40 mg/day (least-squares mean difference -1.2
4 ay, 5 and 160 mg/day, or 10 and 160 mg/day), nebivolol (5 mg/day or 20 mg/day), valsartan (80 mg/day
5                                              Nebivolol (500 ng/kg) reduced INF/AAR by 37% (p < 0.001
6                                              Nebivolol (500 ng/kg), CL 316243 (1 mug/kg), BRL-37344 (
7 his study sought to test the hypothesis that nebivolol, a beta1-antagonist and beta2,3-agonist, may i
8 helial dysfunction in blacks was tested with nebivolol, a beta1-selective agent with vasodilating and
9                         We hypothesized that nebivolol, a vasodilating beta-blocker, could improve en
10  this hypothesis by comparing the effects of nebivolol and atenolol on endothelial function.
11                                              Nebivolol and carvedilol are third-generation beta-adren
12  results demonstrate for the first time that nebivolol and carvedilol induce relaxation of renal glom
13                         We hypothesized that nebivolol and carvedilol stimulate NO release from micro
14                The maximum of NO release for nebivolol and carvedilol was very similar (188+/-14 and
15                                              Nebivolol and CL 316243 increased eNOS phosphorylation a
16                                              Nebivolol and CL 316243 significantly increased myocardi
17 15 to 4 weeks of double-blind treatment with nebivolol and valsartan fixed-dose combination (5 and 80
18                                              Nebivolol and valsartan fixed-dose combination is an eff
19  combination of a vasodilating beta blocker (nebivolol) and an angiotensin II receptor blocker (valsa
20 or the selective beta1-binding of xamoterol, nebivolol, and ICI89406 but does not explain the selecti
21 r the beta1-selective affinity of xamoterol, nebivolol, and ICI89406 but not all beta1-selective comp
22  of the potent antihypertensive beta-blocker nebivolol are reported.
23 etylcholine was significantly increased with nebivolol/bendrofluazide (maximum percentage change in f
24                                              Nebivolol/bendrofluazide and atenolol/bendrofluazide eac
25                                              Nebivolol/bendrofluazide increased both stimulated and b
26  a growth abnormality that was normalized by nebivolol but not by metoprolol.
27 This pathological phenotype was corrected by nebivolol but not metoprolol in a dose-dependent fashion
28                                              Nebivolol but not metoprolol induced endothelium-depende
29                                              Nebivolol could be a promising option for the management
30                                              Nebivolol decreased O2- and ONOO- concentrations and res
31                                              Nebivolol failed to reduce INF after MI/R in beta(3)-AR
32 or beta1-selective affinity of xamoterol and nebivolol, followed by computer-based modeling to provid
33 re, vasodilating beta-blockers, particularly nebivolol, have positive effects on endothelial function
34                                        Thus, nebivolol may offer additional vascular protection in tr
35                               The effects of nebivolol on endothelial nitric oxide (NO), superoxide (
36                  This paper examined whether nebivolol protects the heart via nitric oxide (NO) synth
37      Pretreatment with 1.0 to 5.0 micromol/L nebivolol restored NO bioavailability in endothelial cel
38 bromocriptine, tetrabenazine, rosiglitazone, nebivolol, sorafenib, cabozantinib, tamoxifen, meclizine
39  L-NMMA was significantly improved only with nebivolol treatment (percentage change in forearm blood
40                                              Nebivolol was more potent than metoprolol in improving c
41                               The effects of nebivolol were dose-dependent and not observed with aten
42 8-week treatment periods with either 5 mg of nebivolol with 2.5 mg of bendrofluazide or 50 mg of aten
43                   We compared the effects of nebivolol with metoprolol, a first-generation beta1-sele